Charles River Laboratories International, Inc. and Toxys have announced a strategic collaboration to expand access to ReproTracker®, a cutting-edge, human stem cell-based in vitro assay designed to identify developmental toxicity hazards in pharmaceuticals and chemicals. The partnership aims to accelerate…
Kernal Biologics, Inc., a venture-backed TechBio company transforming the treatment landscape through mRNA-based in vivo cell programming, announced it has been awarded up to $48 million in funding from the Advanced Research Projects Agency for Health (ARPA-H). The award comes…
Membrion, a pioneering ceramic desalination membrane innovator, has successfully completed a $20 million Series B1 funding round, marking a significant milestone in its mission to revolutionize industrial water management. The round was anchored by leading climate-tech and materials investors, including…
Near Space Labs, a leading innovator in stratospheric robotics and Earth observation technology, announced that Tom Chi, founding member of Google X and former head of Project Loon, has joined the company as a strategic investor and board observer. Chi’s…
Copyright Clearance Center (CCC), a global pioneer in voluntary collective licensing and information management solutions, has announced a new collaboration with the China Educational Publications Import & Export Corporation (CEPIEC). CEPIEC is the leading distributor of international scholarly content to…
Merz Therapeutics GmbH, a global leader in neurology-focused specialty pharmaceuticals, today announced the opening of its new affiliate in Warsaw, Poland. This strategic expansion marks a major milestone in the company’s ongoing global growth and underlines its long-term commitment to…
Tidepool, a leading nonprofit innovator in the diabetes technology space, has announced its inclusion as an inaugural member of the Milken Institute’s Women’s Health Network. The milestone marks a significant step forward in recognizing the critical intersection between women’s health…
Aphios Corporation, a leading innovator in botanical pharmaceuticals, green chemistry, and biotechnology, announced today that it has been awarded a Small Business Innovation Research (SBIR) Phase I grant from the National Center for Complementary & Integrative Health (NCCIH) at the…
bioAffinity Technologies Reports Record Q3 2025 Growth for CyPath® Lung Test bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, announced record sales growth for its flagship diagnostic test, CyPath®…
Veristat, a global clinical research organization (CRO) and consultancy specializing in complex clinical studies, announced its participation in the upcoming Clinical Outsourcing Group (COG) – Bay Area 2025 conference, to be held October 21–22, 2025, at the Hyatt Regency San…